Synthetic Biology Market Size, Share & Analysis Report, 2024-2033
The global synthetic biology market size was exhibited at USD 14.09 billion in 2023 and is projected to hit around USD 80.17 billion by 2033, growing at a CAGR of 18.99% during the forecast period 2024 to 2033.
Key Takeaways:
Synthetic Biology Market Report Scope
| Report Coverage | Details |
| Market Size in 2024 | USD 16.77 Billion |
| Market Size by 2033 | USD 80.17 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 18.99% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Technology, Product, Application, End-use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | Bota Biosciences Inc.; Codexis, Inc.; Creative Biogene; CREATIVE ENZYMES; Enbiotix, Inc.; Illumina, Inc.; Merck Kgaa (Sigma-Aldrich Co. LLC); New England Biolabs; Euro fins Scientific; Novozymes; Pareto Bio, Inc.; Scarab Genomics, LLC; Synthego; Synthetic Genomics Inc.; Thermo Fisher Scientific, Inc. |
The increasing scope of synthetic biology applications for multiplexed diagnostics & cellular recording, as well as therapeutic genome editing, is anticipated to surge its demand during the study period. Additionally, the utility of organisms and products from synthetic biology techniques in other sectors, including energy and chemicals, is also likely to impact the overall market growth.
The outbreak of COVID-19 led to an increased usage of synthetic biology products in the past 2 years. Many key pharmaceutical and biotechnology companies as well as synthetic biology players in the industry have increased their research activities globally, by adopting new techniques for producing test kits, therapies, and vaccines for COVID-19. In a study from European Parliament, synthetic biology is considered to be one of the developing technologies. It has the ability to be used in combating COVID-19 infection. Synthetic biology has also been highlighted as a means to accelerate vaccine development by the National Institute of Health in the U.S.
The global market is expected to advance as a result of the growing research and development activities in various fields. To improve conventional biofuel production, players are implementing synthetic biology approaches to enhance performance and increase the utilization of low-cost inputs such as waste. For instance, fashion companies such as Modern Meadow, Bolt Threads, and Vitro Labs are employing biotechnology to develop sustainable materials.
The market witnessed strong investments from private & public partnerships. As per the data published by SynBioBeta, the startups in the synthetic biology industry raised 7.8 billion in investment in 2020, and USD 18.0 billion in 2021. Companies such as Arbor Biotechnologies and DNA Script raised around USD 215 million and USD 167.2 million, respectively. The heavy investment increases the circulation of funds in the market and supports the growth of companies across the supply chain.
Furthermore, advances in genome editing and the presence of bio-foundries, as well as the availability of natural resources and enormous markets, are highlighted as global strengths in synthetic biology to build a bio-based economy. The possible challenges to the field's long-term development, such as insufficient infrastructure and policies, are discussed along with proposals for overcoming them through public-private partnerships, more effective multilateral cooperation, and a well-developed governance framework.
Additionally, players in the market are entering with the latest technologies in order to meet the growing demand and capture untapped avenues of the market. For instance, in November 2021, Creative Biogene released its broad shRNA products to accelerate RNAi research. The company has broad expertise and experience to offer high-quality RNAi products, including shRNA clones and siRNA libraries, intending to provide effective, convenient, and reliable tools to fast-track RNAi research.
Segments Insights:
Technology Insights
The PCR segment held the highest market share of 27.29% in 2023 and the trend is expected to continue throughout the forecast period. Polymerase Chain Reaction (PCR) has emerged as one of the key technologies for the detection and analysis of specific gene sequences. The real-time PCR assays provide high sensitivity and specificity, making it the go-to method for numerous genomic studies based on PCR. This technique is widely used in various areas such as forensic research, DNA cloning, molecular diagnostics, and genomics.
Genome editing technology, on the other hand, is anticipated to expand at a substantial CAGR during the projected period. The anticipated growth of gene-editing tools can be attributed to several advantages associated with synthetic and genetically modified organisms. The ability of gene editing techniques to develop products with desired traits has revolutionized various sectors, including human & animal healthcare and the agricultural sector.
Product Insights
Oligonucleotide/Oligo Pools and Synthetic DNA segment generated a revenue of USD 4,655.86 million in 2023. In several molecular and synthetic biology applications, oligonucleotides are considered the primary point. Increasing adoption of targeted NGS, mutagenesis experiments, DNA computing, and CRISPR gene editing are the major segment drivers for the same. For instance, OligoMix is an innovative and personalized product for genomics discoveries. It synthesizes numerous sequences of oligonucleotide in massive parallel. The cost for the same is lower than 0.8 cents per base.
On the other hand, the enzymes segment is anticipated to expand at a CAGR of 19.26% during the forecasted period. Enzymes are used as catalysts during biochemical reactions. The prospective application of enzymatic synthesis in delivering lengthier genes in a limited turnaround time is anticipated to boost market growth. However, the technology is still in the developing stage and has not yet been commercialized.
Application Insights
The healthcare segment dominated the market and is expected to expand at a CAGR of 19.23% throughout the forecast period. Diagnostic based on synthetic biology provides a highly specific, sensitive, real-time, and non-invasive process for detecting infectious agents, cancer cells, and therapeutics. Researchers employ rational engineering techniques to design novel bio-sensing systems that are dynamic and constituted of a processor, sensor, and reporter.
The segment is also propelled by an increase in neurological disorders such as multiple sclerosis. For instance, as of July 2023, the experts in synthetic biology from the University of Toronto Engineering are developing custom stem cells from the tissues of patients to treat diseases. Such research efforts are anticipated to supplement the segment growth.
End-use Insights
The biotechnology and pharmaceutical companies segment captured the highest revenue share of 55.0% in 2023. Synthetic biology has aided biotech and pharmaceutical companies in the development of new therapeutics for chronic diseases. For instance, Merck utilized synthetic biology techniques to generate Januvia (sitagliptin), a diabetes medication. Moreover, Novartis introduced Kymriah (Tisagenlecleucel) for the treatment of B-cell acute lymphoblastic leukemia.
Furthermore, the academic & government research institutes segment is expected to show steady growth during the forecast period. The R&D sector is considered to be capital-intensive owing to long development periods and approval cycles. R&D expenditure and funding have witnessed a steady increase during the years. According to an article published in September 2020, the R&D spending in the life sciences industry surged 22% from 2021 to 2023.
Regional Insights
North America dominated the regional market with a share of 45.0% in 2023. This major share can be attributed to increasing investment in private companies, favorable regulations, and government assistance. The U.S. majorly concentrates on research in the area of proteomics, drug screening & discovery, and genomics structure prediction, thereby propelling the growth of the synthetic biology market.
The Asia Pacific is estimated to be the fastest-growing region; the significant developments by rising investments in Asia Pacific countries, increasing partnerships & funding in the Chinese market, and increasing collaborations in the field of synthetic biology are among the factors anticipated to drive the growth of the synthetic biology market. Moreover, several Asian countries have recently established national institutes, state-sponsored research programs, and academia-industry collaborations to promote technological innovation for the advancement of synthetic biology.
Some of the prominent players in the Synthetic biology market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global synthetic biology market.
Technology
Product
Application
End-use
By Region
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.8 Global Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Synthetic Biology Market Lineage Outlook
3.2.1 Parent Market Outlook
3.3 Penetration and Growth Prospect Mapping
3.4 Market Driver Analysis
3.4.1 Extensive Applications Of Synthetic Biology
3.4.2 Funding And Assistance From Government And Private Organization
3.4.3 Growing Research And Development Activities In Synthetic Biology
3.5 Market Restraint Analysis
3.5.1 Biosafety, Biosecurity Issue
3.5.2 Ethical Issues And Unintended Consequences
3.6 Market Opportunity Analysis
3.6.1 Development Of Vaccines And Personalized Medicines
3.6.2 Demand For Biofuel
3.7 Market Challenge Analysis
3.7.1 Lack Of Standard Regulation For Synthetic Biology Products
3.8 Business Environment Analysis
3.8.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
3.8.2 Porter’s Five Forces Analysis
3.9 Competitive Analysis
3.9.1 Recent Developments & Impact Analysis, By Key Market Participants
3.9.1.1 Strategy Framework
3.9.1.2 Market Participant Categorization
3.9.1.3 Major Deals & Strategic Alliances Analysis
3.9.1.3.1 Mergers And Acquisitions
3.9.1.3.2 Partnerships
3.9.1.3.3 Agreements
3.9.1.3.4 Synergies, Collaborations, And Other Initiatives
3.9.2 Market Entry Strategies
Chapter 4 Products Business Analysis
4.1 Synthetic Biology Market: Products Movement Analysis
4.2 Oligonucleotide/Oligo Pools And Synthetic Dna
4.2.1 Global Synthetic Biology Market For Oligonucleotide/Oligo Pools And Synthetic Dna Estimates And Forecast, 2021 - 2033
4.3 Enzymes
4.3.1 Global Synthetic Biology Market For Enzymes Synthetic Biology Market Estimates And Forecast, 2021 - 2033
4.4 Cloning Technologies Kits
4.4.1 Global Synthetic Biology Market For Cloning Technologies Kits Synthetic Biology Market Estimates And Forecast, 2021 - 2033
4.5 Xeno-Nucleic Acids
4.5.1 Global Synthetic Biology Market For Xeno-Nucleic Acids Synthetic Biology Market Estimates And Forecast, 2021 - 2033
4.6 Chassis Organism
4.6.1 Global Synthetic Biology Market For Chassis Organism Synthetic Biology Market Estimates And Forecast, 2021 - 2033
Chapter 5 Technology Business Analysis
5.1 Synthetic Biology Market: Technology Movement Analysis
5.2 PCR
5.2.1 Global Synthetic Biology Market For PCR Synthetic Biology Market Estimates And Forecast, 2021 - 2033
5.3 Genome Editing
5.3.1 Global Synthetic Biology Market For Genome Editing Synthetic Biology Market Estimates And Forecast, 2021 - 2033
5.4 NGS
5.4.1 Global Synthetic Biology Market For NGS Synthetic Biology Market Estimates And Forecast,2021 - 2033
5.5 Bioprocessing Technology
5.5.1 Global Synthetic Biology Market For Bioprocessing Technology Synthetic Biology Market Estimates And Forecast, 2021 - 2033
5.6 Others
5.6.1 Global Synthetic Biology Market For Others Synthetic Biology Market Estimates And Forecast, 2021 - 2033
Chapter 6 Application Business Analysis
6.1 Synthetic Biology Market: Application Movement Analysis
6.2 Healthcare
6.2.1 Global Synthetic Biology Market For Healthcare Synthetic Biology Market Estimates And Forecast, 2021 - 2033
6.2.2 Clinical
6.2.2.1 Global Synthetic Biology Market For Clinical Synthetic Biology Market Estimates And Forecast, 2021 - 2033
6.2.2.1.1 Bio/Pharmaceuticals
6.2.2.1.1.1 Global Synthetic Biology Market For Bio/Pharmaceuticals Synthetic Biology Market Estimates And Forecast, 2021 - 2033
6.2.2.1.2 Diagnostics
6.2.2.1.2.1 Global Synthetic Biology Market For Diagnostics Synthetic Biology Market Estimates And Forecast, 2021 - 2033
6.3 Non-Healthcare
6.3.1 Global Synthetic Biology Market For Non-Healthcare Synthetic Biology Market Estimates And Forecast, 2021 - 2033
6.3.1.1 Biotech Crops
6.3.1.1.1 Global Synthetic Biology Market For Biotech Crops Synthetic Biology Market Estimates And Forecast, 2021 - 2033
6.3.1.2 Specialty Chemicals
6.3.1.2.1 Global Synthetic Biology Market For Specialty Chemicals Synthetic Biology Market Estimates And Forecast, 2021 - 2033
6.3.1.3 Bio-Fuels
6.3.1.3.1 Global Synthetic Biology Market For Bio-Fuels Synthetic Biology Market Estimates And Forecast, 2021 - 2033
6.3.1.4 Others
6.3.2 Global Synthetic Biology Market For Others Synthetic Biology Market Estimates And Forecast, 2021 - 2033
Chapter 7 End-Use Business Analysis
7.1 Synthetic Biology Market: End-Use Movement Analysis
7.2 Biotechnology And Pharmaceutical Companies
7.2.1 Global Synthetic Biology Market For Biotechnology And Pharmaceutical Companies Estimates And Forecast, 2021 - 2033
7.3 Academic & Government Research Institutes
7.3.1 Global Synthetic Biology Market For Academic & Government Research Institutes Estimates And Forecast, 2021 - 2033
7.4 Others
7.4.1 Global Synthetic Biology Market For Others Estimates And Forecast, 2021 - 2033
Chapter 8 Regional Business Analysis
8.1 Synthetic Biology Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Synthetic Biology Market Estimates And Forecast, 2021 - 2033
8.2.2 U.S.
8.2.2.1 U.S. Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.2.2.2 U.S. Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.2.2.3 U.S. Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.2.2.4 U.S. Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.2.3 Canada
8.2.3.1 Canada Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.2.3.2 Canada Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.2.3.3 Canada Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.2.3.4 Canada Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.3 Europe
8.3.1 Europe Synthetic Biology Market Estimates And Forecast, 2017-2028
8.3.2 Uk
8.3.2.1 Uk Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.3.2.2 Uk Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.3.2.3 Uk Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.3.2.4 Uk Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.3.3 Germany
8.3.3.1 Germany Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.3.3.2 Germany Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.3.3.3 Germany Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.3.3.4 Germany Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.3.4 France
8.3.4.1 France Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.3.4.2 France Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.3.4.3 France Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.3.4.4 France Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.3.5 Italy
8.3.5.1 Italy Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.3.5.2 Italy Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.3.5.3 Italy Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.3.5.4 Italy Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.3.6 Spain
8.3.6.1 Spain Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.3.6.2 Spain Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.3.6.3 Spain Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.3.6.4 Spain Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.3.7 Russia
8.3.7.1 Russia Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.3.7.2 Russia Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.3.7.3 Russia Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.3.7.4 Russia Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.4 Asia-Pacific
8.4.1 Asia-Pacific Synthetic Biology Market Estimates And Forecast, 2021 - 2033
8.4.2 China
8.4.2.1 China Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.4.2.2 China Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.4.2.3 China Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.4.2.4 China Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.4.3 Japan
8.4.3.1 Japan Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.4.3.2 Japan Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.4.3.3 Japan Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.4.3.4 Japan Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.4.4 India
8.4.4.1 India Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.4.4.2 India Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.4.4.3 India Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.4.4.4 India Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.4.5 Australia
8.4.5.1 Australia Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.4.5.2 Australia Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.4.5.3 Australia Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.4.5.4 Australia Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.4.6 Singapore
8.4.6.1 Singapore Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.4.6.2 Singapore Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.4.6.3 Singapore Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.4.6.4 Singapore Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.5 Latin America
8.5.1 Latin America Synthetic Biology Market Estimates And Forecast, 2021 - 2033
8.5.2 Brazil
8.5.2.1 Brazil Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.5.2.2 Brazil Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.5.2.3 Brazil Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.5.2.4 Brazil Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.5.3 Mexico
8.5.3.1 Mexico Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.5.3.2 Mexico Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.5.3.3 Mexico Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.5.3.4 Mexico Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.6 Middle East And Africa
8.6.1 Middle-East And Africa Synthetic Biology Market Estimates And Forecast, 2021 - 2033
8.6.2 Saudi Arabia
8.6.2.1 Saudi Arabia Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.6.2.2 Saudi Arabia Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.6.2.3 Saudi Arabia Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.6.2.4 Saudi Arabia synthetic biology market estimates and forecast, by end-use, 2021 - 2033
8.6.3 South Africa
8.6.3.1 South Africa Synthetic Biology Market Estimates And Forecast, By Product, 2021 - 2033
8.6.3.2 South Africa Synthetic Biology Market Estimates And Forecast, By Technology, 2021 - 2033
8.6.3.3 South Africa Synthetic Biology Market Estimates And Forecast, By Application, 2021 - 2033
8.6.3.4 South Africa Synthetic Biology Market Estimates And Forecast, By End-Use, 2021 - 2033
8.6.4 UAE
8.6.4.1 UAE synthetic biology market estimates and forecast, by product, 2021 - 2033
8.6.4.2 UAE synthetic biology market estimates and forecast, by technology, 2021 - 2033
8.6.4.3 UAE synthetic biology market estimates and forecast, by application, 2021 - 2033
8.6.4.4 UAE synthetic biology market estimates and forecast, by end-use, 2021 - 2033
Chapter 9 COMPANY PROFILE
9.1 BOTA BIOSCIENCES INC.
9.1.1 Company overview
9.1.2 Financial Performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 CODEXIS, INC.
9.2.1 Company overview
9.2.2 Financial Performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 CREATIVE BIOGENE.
9.3.1 Company overview
9.3.2 Financial Performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 CREATIVE ENZYMES.
9.4.1 Company overview
9.4.2 Financial Performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 ENBIOTIX, INC.
9.5.1 Company overview
9.5.2 Financial Performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 EUROFINS SCIENTIFIC
9.6.1 Company overview
9.6.2 Financial Performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.7 ILLUMINA, INC.
9.7.1 Company overview
9.7.2 Financial Performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.8 MERCK KGAA.
9.8.1 SIGMA-ALDRICH CO. LLC
9.8.2 Company overview
9.8.3 Financial Performance
9.8.4 Product benchmarking
9.8.5 Strategic initiatives
9.9 NEW ENGLAND BIOLABS.
9.9.1 Company overview
9.9.2 Financial Performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 NOVOZYMES
9.10.1 Company overview
9.10.2 Financial Performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.11 PARETO BIO, INC.
9.11.1 Company overview
9.11.2 Financial Performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.12 SCARAB GENOMICS, LLC
9.12.1 Company overview
9.12.2 Financial Performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.13 SYNTHEGO
9.13.1 Company overview
9.13.2 Financial Performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.14 SYNTHETIC GENOMICS INC.
9.14.1 Company overview
9.14.2 Financial Performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.15 THERMO FISHER SCIENTIFIC, INC.
9.15.1 Company overview
9.15.2 Financial Performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers